FIT:MATCH showcased their QuadraScan technology at MLS Next Fest, scanning young athletes and providing body composition insights for player development. Read more on FIT:MATCH →
TETmedical appointed diagnostics commercialization executive Arjun Ishwar as chief commercial officer as NSE-FAST advances toward pivotal study.
A peer-reviewed preclinical study found AVA-003 outperformed chlorhexidine against Candida auris on skin, advancing AvantGuard’s development program.
